Skip to main navigation
Go to Nurix Therapeutics, Inc. homepage
Nurix Therapeutics, Inc.
  • Inside The Science
    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library
  • Advancing Our Pipeline
    • Pipeline
    • Clinical Trials
  • Learn About Us
    • Our Story
    • Leadership
    • Partnering
    • Contact Us
  • Work at Nurix
    • Our Culture
    • Explore Jobs
Patients
 Patients
Investors & News
 Investors & News
Go to Nurix Therapeutics, Inc. homepage
Nurix Therapeutics, Inc.
  • Inside The Science
    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library
  • Advancing Our Pipeline
    • Pipeline
    • Clinical Trials
  • Learn About Us
    • Our Story
    • Leadership
    • Partnering
    • Contact Us
  • Work at Nurix
    • Our Culture
    • Explore Jobs

FOR INVESTORS

Biography

  • Overview
  • Press Releases
  • Events
  • Financial Info
  • Stock
  • Governance
  • FAQs

Christopher Liu

Lucid Capital Markets
    Print Page (opens in new tab)

    Print Page

    Contact IR (opens in new tab)

    Contact IR

    RSS (opens in new tab)

    RSS

    Email Alerts (opens in new tab)

    Email Alerts

    Go to Nurix Therapeutics, Inc. homepage

    WHERE SCIENCE EXPANDS POSSIBILITIES

    Inside The Science

    • DEL-AI Discovery Engine
    • Targeted Protein Degradation
    • Resource Library

    Advancing Our Pipeline

    • Pipeline
    • Clinical Trials

    Learn About Us

    • Our Story
    • Leadership
    • Partnering
    • Contact Us

    Work at Nurix

    • Our Culture
    • Explore Jobs

    For Investors

    • News
    • Financial Information
    • Stock Information
    • Corporate Governance
    • FAQs
    • Investor Contact

    For Patients

    • Resources

    ©2026 Nurix Therapeutics, Inc.

    Privacy Policy

    Terms of Use

    Cookie Policy

    Privacy Policy

    Terms of Use

    Cookie Policy